Effect of First-Line Combination Systemic Therapy on Favorable-Risk Clear Cell Renal Cell Carcinoma: A Retrospective Study.

Although this difference did not reach statistical significance in unadjusted analysis ( p = 0.25), a subsequent multivariate regression model identified type of therapy and liver metastasis as independent predictors for PFS ( Table 2 ).

also in 111,027 other papers